Publications about us

  • Annual Pharmacovigilance Report 2016 of the Danish Medicines Agency

    | 08 June 2017 |

    The number of reports on suspected adverse reactions submitted to the DKMA in 2016 more or less levelled the year before. We received less ADR reports from physicians, but ADR reports involving patien

  • Our strategy 2017-2021

    | 15 December 2016 |

    The Danish Medicines Agency: Among Europe's best in class! This is the title of our strategy for 2017-2021, which emphasises our commitment to both public health and growth in Denmark.

  • Annual pharmacovigilance report 2015

    | 25 April 2016 |

    Openness and dialogue are keywords in the Danish Medicines Agency's work with adverse reactions. In 2015, this was to become particularly important. Since 2009, almost 2,000 girls and young women had reported suspected adverse reactions to the Gardasil® HPV vaccine, and patient organisations and the media wanted us to join the debate.

  • Annual report 2014 - Clinical trials of medicines

    | 06 July 2015 |

    In 2014, DHMA received 284 applications for authorisation of clinical trials of medicines in humans, which is a decline of 3% on 2013. Commercial sponsors applied for 162 trials and researchers (non-c

  • Annual report 2013 clinical trials of medicines in humans

    | 03 July 2014 |

    The Danish Health Authority's has published its annual report 2013 on clinical trials of medicines in humans.

  • Danish Medicines Agency annual accounts 2010

    | 27 April 2011 |

    The full report, which is in Danish only, is available via the box.

  • Performance contract 2010/2011

    | 30 March 2011 |

    The Danish Medicines Agency and the Ministry of Interior and Health have signed a performance contract.

  • Performance contract 2009

    | 03 July 2009 |

    The Danish Medicines Agency and the Ministry of Health and Prevention have agreed upon a performance contract, which is valid for 2009. The contract, which is in Danish only, focuses on external targets that cover the Danish Medicines Agency's tasks to the greatest extent possible.

  • Danish Medicines Agency annual accounts 2008

    | 17 April 2009 |

    In 2008, the Danish Medicines Agency achieved a target performance of 91.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of four in every five sub-requirements. Overall, we find that we delivered good technical results in 2008.

  • Performance contract 2008

    | 19 December 2008 |

  • Danish Medicines Agency annual report 2007

    | 10 September 2008 |

    The annual report 2007 takes you through important activities within the Danish Medicines Agency in 2007. On a number of theme pages, we also tell about projects that strengthen our cooperation with the business sector, our relations to consumers and our involvement in European development.

  • Danish Medicines Agency annual accounts 2007

    | 22 April 2008 |

    In 2007, the Danish Medicines Agency achieved a target performance of 93.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of three in every four sub-requirements. Overall, we assess that we delivered good technical results in 2007, among other things, based on the fact that the most strategically important performance requirements were fulfilled.

  • Danish Medicines Agency annual report 2006

    | 12 September 2007 |

    In the report for 2006, we have chosen to bring you samples of how we put our values into practice in our daily activities. Read more about how we have been competent, trustworthy, attentive, receptive and European from the fact box to the right.

  • Danish Medicines Agency annual accounts 2006

    | 17 April 2007 |

    The Danish Medicines Agency's performance contract with the Ministry of the Interior and Health for 2006 comprises 12 targets made up of 28 performance requirements and 58 sub-requirements. Furthermore, the performance contract includes one focus area.

  • Danish Medicines Agency annual report 2005

    | 29 August 2006 |

    The effort on ensuring consumer safety became very visible in the spring of 2005 when we decided to set up an individual division under this heading. Enhancing the safety of medicine users will also be the result of the new Medicines Act which entered into force in December.

Did you get answers to your questions?

Please tell us how we can improve our website?